| Autor: |
Anandan, Satish, Kotebagilu, Namratha Pai, Shivanna, Lohith Mysuru, Urooj, Asna |
| Zdroj: |
Journal of Biologically Active Products from Nature; September 2017, Vol. 7 Issue: 5 p391-400, 10p |
| Abstrakt: |
AbstractAdvanced glycation end products (AGEs) formation is associated with different pathophysiological conditions, including diabetes mellitus. Our study aimed at screening the effect of 80 % aqueous methanol extract of leaves (AQME) of three commercial varieties of Morus indica(G4, V1 and S36) and two wild varieties of Morussp., (Morus laevigata- ML and Morus serrata-MS) on in vitroprotein glycation in BSA-glucose model. G4 exhibited the highest AGEs inhibition and metal ion chelation. It also inhibited cross-linking of protein glycation and protein aggregation. The G4 extract had a total polyphenol content of 96 mg GAE g-1and flavonoid content of 55.3 mg CE g-1. C-glycosyl flavonoids were identified and quantified in G4 by UPLC/MS. This is the first study reporting the presence of luteolin (258 μg g-1) and apigenin (164 μg g-1) in G4 variety which possess the most active anti-glycation property. Thus, G4 could be protective against hyperglycemia-mediated protein damage. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
